148471-91-4

148471-91-4 structure

Name: Hematoporphyrin monomethyl ether
Chemical Name: 3,3'-[7-(1-Hydroxyethyl)-12-(1-methoxyethyl)-3,8,13,17-tetramethy l-2,18-porphyrindiyl]dipropanoic acid
CAS Number: 148471-91-4
Molecular Formula: C₃₅H₄₀N₄O₆
Molecular Weight: 612.715
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2018-06-02 08:00:00
Modify Date: 2024-01-03 23:29:17
Hematoporphyrin monomethyl ether, second generation of porphyrin-related photosensitizer, is characterized by its single form, high yield of singlet oxygen, high selectivity, and low toxicity, which has been widely used in the diagnosis and treatment of various tumors, including lung cancer, bladder cancer, and nevus flammeus and brain glioma[1].

Name	3,3'-[7-(1-Hydroxyethyl)-12-(1-methoxyethyl)-3,8,13,17-tetramethy l-2,18-porphyrindiyl]dipropanoic acid
Synonyms	HeMatoporphyrinMonoMethylether 21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-hydroxyethyl)-12-(1-methoxyethyl)-3,8,13,17-tetramethyl- 3,3'-[7-(1-Hydroxyethyl)-12-(1-methoxyethyl)-3,8,13,17-tetramethyl-2,18-porphyrindiyl]dipropanoic acid Hematoporphyrinmonomethyl Ether

Description	Hematoporphyrin monomethyl ether, second generation of porphyrin-related photosensitizer, is characterized by its single form, high yield of singlet oxygen, high selectivity, and low toxicity, which has been widely used in the diagnosis and treatment of various tumors, including lung cancer, bladder cancer, and nevus flammeus and brain glioma[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer
In Vitro	Hematoporphyrin monomethyl ether (HMME) is a novel and promising porphyrin-related photosensitizer for photodynamic therapy (PDT). HMME-PDT can induce cell deaththrough both necrosis and apoptosis in HeLa cells. ROS, such as singlet oxygen and hydroxyl radical, generated in HeLa cells play a decisive role in HMME-PDT-induced cell death[2].
References	[1]. Ding X, et al. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett. 2004;216(1):43-54.